Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11633405 Steroid hormone pharmaceutical formulations

Patent 11633405 was granted and assigned to TherapeuticsMD on April, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Veeran Gowda Kadajji0

Mafruhul Bari0

Peter H. R. Persicaner0

Thorsteinn Thorsteinsson0

Annette Shadiack0

Date of Patent

April 25, 2023

0

Patent Application Number

171691030

Date Filed

February 5, 2021

0

Patent Citations

US Patent 10471072 Vaginal inserted estradiol pharmaceutical compositions and methods

0

US Patent 10537581 Vaginal inserted estradiol pharmaceutical compositions and methods

0

US Patent 10568891 Vaginal inserted estradiol pharmaceutical compositions and methods

0

US Patent 10806697 Vaginal inserted estradiol pharmaceutical compositions and methods

0

US Patent 10835487 Vaginal inserted estradiol pharmaceutical compositions and methods

0

US Patent 10888516 Soluble estradiol capsule for vaginal insertion

0

US Patent 11065197 Soluble estradiol capsule for vaginal insertion

0

US Patent 11116717 Soluble estradiol capsule for vaginal insertion

0

...

Patent Primary Examiner

0

This disclosure provides pharmaceutical compositions for delivering estradiol to a subject in need thereof, as well as methods of administering the compositions, and methods of using them.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11633405 Steroid hormone pharmaceutical formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool